查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1675321

2025 年至 2033 年口服抗生素市场报告，按类别、应用（社区获得性呼吸道感染、泌尿道感染、牙科和其他）、药物来源、活性范围、药物类型和地区划分

Oral Antibiotics Market Report by Class, Application (Community-acquired Respiratory Tract Infections, Urinary Tract Infections, Dental and Others), Drug Origin, Spectrum of Activity, Drug Type, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球口服抗生素市场规模达到 210.78 亿美元。传染病的盛行率不断上升、老年人口不断扩大、对抗药性细菌的有效治疗需求不断增加以及个人化医疗和基因组学的发展趋势是推动市场发展的一些关键因素。

口服抗生素是一种主要用于抑制细菌生长或消除体内细菌的药物。它们通常透过口服并广泛应用于各种医疗用途。口服抗生素治疗的感染类型多种多样，包括皮肤、耳朵、喉咙和泌尿道感染等常见疾病，以及某些类型的肺炎等更复杂的疾病。这些抗生素分为不同的类别，每种类别都有不同的作用机制。一些常用的药物类别包括青霉素类、氟喹诺酮类、四环素类和大环内酯类。每种类型针对不同类型的细菌，对特定的细菌感染更有效。例如，青霉素广泛用于治疗链球菌感染，而氟喹诺酮类药物可用于对抗某些革兰氏阴性细菌。因此，口服抗生素是现代医疗保健的重要组成部分，并被医疗保健专业人员广泛使用，以成功治疗多种细菌感染。

口服抗生素市场趋势：

传染病的日益流行和公众对这些疾病的可用治疗方案的认识的提高是支持市场成长的主要因素。此外，老年人口的不断增加使得老年人更容易感染此类疾病，这也是推动市场成长的另一个主要因素。此外，抗生素管理计画也不断增加，旨在鼓励广泛使用抗生素，减缓抗生素抗药性的出现，并确保这些药物的长期有效性。同时，抗生素抗药性问题的日益严重，迫使研究人员和製药公司修改现有抗生素类别，开发能够治疗多重抗药性细菌的新型抗生素，从而加速产品的采用率。此外，领先的製药公司和研究机构正在药物研发过程中利用人工智慧 (AI) 和机器学习 (ML) 来预测细菌抗药性模式、了解药物-细菌相互作用并加快新型抗生素的发现。同时，个人化医疗和基因组学的出现催化了市场的成长，个人化医疗和基因组学透过考虑患者的基因组成等因素来为个别患者量身定制抗生素治疗，以提高治疗效果并最大限度地减少副作用。其他因素，包括对抗药性细菌的有效治疗需求不断增加、医疗保健基础设施的改善、新型口服抗生素的不断推出以及对研发（R&D）活动的​​大量投资，预计也将推动未来几年的市场成长。

本报告回答的关键问题：

  • 全球口服抗生素市场迄今表现如何？
  • 全球口服抗生素市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球口服抗生素市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家拥有最具吸引力的口服抗生素市场？
  • 根据类别，市场是如何分類的？
  • 口服抗生素市场上最具吸引力的是哪一类药物？
  • 根据应用，市场区隔是怎样的？
  • 口服抗生素市场中最具吸引力的应用是什么？
  • 根据毒品来源，市场如何划分？
  • 口服抗生素市场最具吸引力的药源是哪一个？
  • 依活动范围，市场如何划分？
  • 口服抗生素市场上最具吸引力的业务范围是什么？
  • 根据药品类型，市场分布如何？
  • 口服抗生素市场上最具吸引力的药物类型是哪一种？
  • 全球口服抗生素市场的竞争结构是怎么样的？
  • 全球口服抗生素市场的主要参与者/公司有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球口服抗生素市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第六章：市场细分：依类别

  • β-内酰胺和β-内酰胺酶抑制剂
    • 关键部分
      • 青霉素
      • 头孢菌素
      • 其他的
  • 奎诺酮类
  • 大环内酯类
  • 其他的

第七章：市场区隔：依应用

  • 社区型呼吸道感染 (CARTI)
    • 关键部分
      • 上呼吸道感染 (URTI)
      • 下呼吸道感染 (LRTI)
  • 泌尿道感染 (UTI)
  • 牙科
    • 关键部分
      • 组合
      • 单药疗法
  • 其他的

第 8 章：市场区隔：依药物来源

  • 自然的
  • 半合成
  • 合成的

第九章：市场区隔：依活动范围

  • 广效抗生素
  • 窄谱抗生素

第 10 章：市场区隔：依药物类型

  • 品牌
  • 泛型

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：驱动因素、限制因素与机会

  • 概述
  • 驱动程式
  • 限制
  • 机会

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bayer AG
    • Cipla Inc
    • Gilead Sciences Inc
    • Janssen Inc. (Johnson & Johnson Services, Inc)
    • Pfizer Inc.
    • Roche Holding AG
    • Sun Pharmaceutical Industries Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A8355

The global oral antibiotics market size reached USD 21,078.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 27,949.3 Million by 2033, exhibiting a growth rate (CAGR) of 3.18% during 2025-2033. The increasing prevalence of infectious diseases, expanding geriatric population, escalating demand for effective treatments against drug-resistant bacteria, and the growing trend of personalized medicine and genomics represent some of the key factors driving the market.

Oral antibiotics are pharmaceutical agents primarily prescribed to inhibit bacterial growth or eliminate bacteria from the body. They are usually taken by mouth and are utilized across a wide range of medical applications. The types of infections treated by oral antibiotics vary and include common ailments such as skin, ear, throat, and urinary tract infections and more complex conditions like certain types of pneumonia. These antibiotics are categorized into different classes, each with a distinct mechanism of action. Some commonly prescribed classes include penicillins, fluoroquinolones, tetracyclines, and macrolides. Each class targets different types of bacteria and is more effective for specific bacterial infections. For instance, penicillins are widely used for streptococcal infections, while fluoroquinolones may be chosen to combat certain gram-negative bacteria. As a result, oral antibiotics are a key element of modern healthcare and are widely prescribed by healthcare professionals to enable the successful treatment of numerous bacterial infections.

Oral Antibiotics Market Trends:

The increasing prevalence of infectious diseases and the rising public awareness about the available treatment options for these conditions represent the primary factors supporting market growth. Moreover, the expanding geriatric population that is more susceptible to developing such infections is another major factor fueling the market growth. In addition, there has been a rise in antibiotic stewardship programs aimed at encouraging the widespread use of antibiotics, slowing down the emergence of antibiotic resistance, and ensuring the prolonged effectiveness of these drugs. Along with this, the growing issue of antibiotic resistance has compelled researchers and pharmaceutical companies to modify existing classes and develop new antibiotics capable of treating multi-drug resistant bacteria, thereby accelerating the product adoption rate. Furthermore, the leading pharmaceutical companies and research institutes are leveraging artificial intelligence (AI) and machine learning (ML) in the drug discovery process to predict bacterial resistance patterns, understand drug-bacteria interactions, and expedite the discovery of novel antibiotics. In line with this, the emergence of personalized medicine and genomics, which involves tailoring antibiotic treatment to individual patients by considering factors such as their genetic makeup to enhance treatment effectiveness and minimize side effects, has catalyzed market growth. Other factors, including escalating demand for effective treatments against drug-resistant bacteria, improving healthcare infrastructure, the continual launch of novel oral antibiotics, and heavy investments in research and development (R&D) activities, are also anticipated to propel the market growth in the coming years.

Key Market Segmentation:

Class Insights:

  • Beta Lactam and Beta Lactamase Inhibitors
  • Penicillin
  • Cephalosporin
  • Others
  • Quinolone
  • Macrolide
  • Others

Application Insights:

  • Community-acquired Respiratory Tract Infections (CARTIs)
  • Upper Respiratory Tract Infections (URTI)
  • Lower Respiratory Tract Infections (LRTIs)
  • Urinary Tract Infections (UTIs)
  • Dental
  • Combination
  • Monotherapies
  • Others

Drug Origin Insights:

  • Natural
  • Semisynthetic
  • Synthetic

Spectrum of Activity Insights:

  • Broad-spectrum Antibiotic
  • Narrow Spectrum Antibiotic

Drug Type Insights:

  • Branded
  • Generics

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific was the largest market for oral antibiotics. Some of the factors driving the Asia-Pacific oral antibiotics market included its aging population, growing burden of infectious diseases, high healthcare expenditure, the presence of various key players, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global oral antibiotics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bayer AG, Cipla Inc., Gilead Sciences Inc., Janssen Inc. (Johnson & Johnson Services, Inc.), Pfizer Inc., Roche Holding AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global oral antibiotics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global oral antibiotics market?
  • What is the impact of each driver, restraint, and opportunity on the global oral antibiotics market?
  • What are the key regional markets?
  • Which countries represent the most attractive oral antibiotics market?
  • What is the breakup of the market based on the class?
  • Which is the most attractive class in the oral antibiotics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the oral antibiotics market?
  • What is the breakup of the market based on the drug origin?
  • Which is the most attractive drug origin in the oral antibiotics market?
  • What is the breakup of the market based on the spectrum of activity?
  • Which is the most attractive spectrum of activity in the oral antibiotics market?
  • What is the breakup of the market based on the drug type?
  • Which is the most attractive drug type in the oral antibiotics market?
  • What is the competitive structure of the global oral antibiotics market?
  • Who are the key players/companies in the global oral antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oral Antibiotics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Class

  • 6.1 Beta Lactam and Beta Lactamase Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Penicillin
      • 6.1.2.2 Cephalosporin
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Quinolone
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Macrolide
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Community-acquired Respiratory Tract Infections (CARTIs)
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Upper Respiratory Tract Infections (URTI)
      • 7.1.2.2 Lower Respiratory Tract Infections (LRTIs)
    • 7.1.3 Market Forecast
  • 7.2 Urinary Tract Infections (UTIs)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dental
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Combination
      • 7.3.2.2 Monotherapies
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Drug Origin

  • 8.1 Natural
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Semisynthetic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Synthetic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Spectrum of Activity

  • 9.1 Broad-spectrum Antibiotic
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Narrow Spectrum Antibiotic
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Drug Type

  • 10.1 Branded
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Generics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bayer AG
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Cipla Inc
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Gilead Sciences Inc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Janssen Inc. (Johnson & Johnson Services, Inc)
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Pfizer Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Roche Holding AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Sun Pharmaceutical Industries Ltd
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Teva Pharmaceutical Industries Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Oral Antibiotics Market: Major Drivers and Challenges
  • Figure 2: Global: Oral Antibiotics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Oral Antibiotics Market: Breakup by Class (in %), 2024
  • Figure 5: Global: Oral Antibiotics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Oral Antibiotics Market: Breakup by Drug Origin (in %), 2024
  • Figure 7: Global: Oral Antibiotics Market: Breakup by Spectrum of Activity (in %), 2024
  • Figure 8: Global: Oral Antibiotics Market: Breakup by Drug Type (in %), 2024
  • Figure 9: Global: Oral Antibiotics Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oral Antibiotics (Quinolone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oral Antibiotics (Quinolone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oral Antibiotics (Macrolide) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oral Antibiotics (Macrolide) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oral Antibiotics (Other Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oral Antibiotics (Other Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oral Antibiotics (Dental) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oral Antibiotics (Dental) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oral Antibiotics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oral Antibiotics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Oral Antibiotics (Natural) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Oral Antibiotics (Natural) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Oral Antibiotics (Semisynthetic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Oral Antibiotics (Semisynthetic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Oral Antibiotics (Synthetic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Oral Antibiotics (Synthetic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Oral Antibiotics (Branded) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Oral Antibiotics (Branded) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Oral Antibiotics (Generics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Oral Antibiotics (Generics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Oral Antibiotics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Oral Antibiotics Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Oral Antibiotics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Oral Antibiotics Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Oral Antibiotics Industry: Value Chain Analysis
  • Figure 91: Global: Oral Antibiotics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oral Antibiotics Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Oral Antibiotics Market Forecast: Breakup by Class (in Million USD), 2025-2033
  • Table 3: Global: Oral Antibiotics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Oral Antibiotics Market Forecast: Breakup by Drug Origin (in Million USD), 2025-2033
  • Table 5: Global: Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (in Million USD), 2025-2033
  • Table 6: Global: Oral Antibiotics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 7: Global: Oral Antibiotics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Oral Antibiotics Market: Competitive Structure
  • Table 9: Global: Oral Antibiotics Market: Key Players